Abstract
A multiinstitutional cooperative study comparing carbamazepine (Tegretol) with chlorpromazine was performed using a controlled, double-blind trial design. In a series of 63 cases of endogenous manic psychosis, carbamazepine's clinical utility and efficacy, characteristics of therapeutic effect, and side effects were evaluated. Carbamazepine and chlorpromazine were given by a fixed, but flexible, method at an equipotent ratio of 2∶1, starting from the initial dosages of 300 and 150 mg, respectively. The overall improvement rate, based on the number of cases showing moderate to marked amelioration of manic symptoms, was 70% in the carbamazepine group and 60% in the chlorpromazine group. No significant differences were found between the two groups. Improvements in basic mood, insomnia, headache and lassitude, and diurnal fluctuations of mood tended to be characteristic of carbamazepine efficacy for mania compared with the effects of chlorpromazine. The onset of therapeutic effect was within 10 days of treatment in 65.7% of the patients receiving carbamazepine and 50% receiving chlorpromazine. The incidence of side effects was significantly lower in the carbamazepine group than in the chlorpromazine group. It was suggested that carbamazepine is potentially useful drug for the treatment of the manic state.
Similar content being viewed by others
References
Cade, J. F.: Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 36, 349–352 (1949)
Cereghino, J. J., Brock, J. T., Van Meter, J. C., Penry, J. K., Smith, L. D., White, B. G.: Carbamazepine for epilepsy. A controlled prospective evaluation. Neurology 24, 401–410 (1974)
Furukawa, T., Ushizima, I., Ono, N.: Modifications by lithium of behavioral responses to methamphetamine and tetrabenazine, Psychopharmacologia 42, 243–248 (1975)
Johnson, G., Gershon, S., Burdock, E., Floyd, A., Hekimian, L.: Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. Br. J. Psychiatry 119, 267–276 (1971)
Landolt, H.: The psychopathology of epileptic twilight states, their EEG and their treatment. Zürich: Swiss Institute for Epileptics (1965)
Okuma, T., Kishimoto, A., Inoue, K.: Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report. Folia Psychiatr. Neurol. Jpn. 27, 283–297 (1973)
Okuma, T., Kishimoto, A., Inoue, K.: Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. Seishin-igaku 17, 617–630 (1975) (in Japanese)
Prien, R. F., Caffey, E. M., Jr., Klett, C. J.: Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Arch. Gen. Psychiatry 26, 146–153 (1972a)
Prien, R. F., Caffey, E. M., Jr., Klett, C. J.: Relationship between Serum lithium level and clinical response in acute manic treated with lithium. Br. J. Psychiatry 120, 409–414 (1972b)
Prien, R. F., Klett, G. J., Caffey, E. M., Jr.: Lithium carbonate and imipramine in prevention of affective episodes. Arch. Gen. Psychiatry 29, 420–425 (1973)
Rodin, R. A., Rim, C. S., Rennick, P. M.: The effects of carbamazepine on patients with psychomotor epilepsy: Results of a double-blind study. Epilepsia 15, 547–561 (1974)
Siegel, S.: Nonparametric statistics for the behavioral sciences. International Student Edition, pp. 96–104. New York: McGraw-Hill 1956
Takahashi, R., Ito, K., Ito, H., Kurihara, M., Saito, M., Sakuma, A., Watanabe, M.: Comparison of efficacy of lithium carbonate and chlorpromazine in mania by double-blind controlled study. Rinsho-Hyoka 2, 23–45 (1974) (in Japanese)
Takahashi, R., Sakuma, A., Itoh, K., Itoh, K., Kurihara, M., Saito, M., Watanabe, M.: Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Arch. Gen. Psychiatry 32, 1310–1318 (1975)
Takezaki, H., Hanaoka, M.: The use of carbamazepine (Tegretol) in the control of manic-depressive psychosis and other manic depressive states. Seishin-igaku 13, 173–183 (1971) (in Japanese)
Toru, M.: Side effects of psychotropic drugs: An analysis of data obtained from double-blind comparative studies in Japan. Seishin-igaku 16, 659–664 (1974) (in Japanese)
World Health Organization: International classification of diseases, 9th revision, pp. 185–187. Geneva 1973
Yogi, H.: Central nervous actions of carbamazepine. J. Yonago Med. Assoc. 28, 182–195 (1977) (in Japanese)
Author information
Authors and Affiliations
Additional information
Revised version of a paper read at the Sixth World Congress of Psychiatry, Hawaii, August 1977
Rights and permissions
About this article
Cite this article
Okuma, T., Inanaga, K., Otsuki, S. et al. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study. Psychopharmacology 66, 211–217 (1979). https://doi.org/10.1007/BF00428308
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00428308